1334 OBT698: a promising novel agonistic antibody for immuno-oncology and its potential as a cancer therapy for solid tumors
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797629079406510080 |
|---|---|
| author | Chantia Carroll Arnima Bisht Chander Peddaboina Harald Haeske Christian Rohlff |
| author_facet | Chantia Carroll Arnima Bisht Chander Peddaboina Harald Haeske Christian Rohlff |
| author_sort | Chantia Carroll |
| collection | DOAJ |
| first_indexed | 2024-03-11T10:48:22Z |
| format | Article |
| id | doaj.art-bffa6301ff2f495f8400f23d5eb82290 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T10:48:22Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-bffa6301ff2f495f8400f23d5eb822902023-11-13T20:55:06ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.13341334 OBT698: a promising novel agonistic antibody for immuno-oncology and its potential as a cancer therapy for solid tumorsChantia Carroll0Arnima Bisht1Chander Peddaboina2Harald Haeske3Christian Rohlff4Atreca, Inc, South San Francisco, CA, USA1Oxford BioTherapeutics Ltd, San Jose, CA, USA1Oxford BioTherapeutics Ltd, San Jose, CA, USA2Oxford BioTherapeutics Ltd, Abingdon, Oxfordshire, UK2Oxford BioTherapeutics Ltd, Abingdon, Oxfordshire, UK |
| spellingShingle | Chantia Carroll Arnima Bisht Chander Peddaboina Harald Haeske Christian Rohlff 1334 OBT698: a promising novel agonistic antibody for immuno-oncology and its potential as a cancer therapy for solid tumors Journal for ImmunoTherapy of Cancer |
| title | 1334 OBT698: a promising novel agonistic antibody for immuno-oncology and its potential as a cancer therapy for solid tumors |
| title_full | 1334 OBT698: a promising novel agonistic antibody for immuno-oncology and its potential as a cancer therapy for solid tumors |
| title_fullStr | 1334 OBT698: a promising novel agonistic antibody for immuno-oncology and its potential as a cancer therapy for solid tumors |
| title_full_unstemmed | 1334 OBT698: a promising novel agonistic antibody for immuno-oncology and its potential as a cancer therapy for solid tumors |
| title_short | 1334 OBT698: a promising novel agonistic antibody for immuno-oncology and its potential as a cancer therapy for solid tumors |
| title_sort | 1334 obt698 a promising novel agonistic antibody for immuno oncology and its potential as a cancer therapy for solid tumors |
| work_keys_str_mv | AT chantiacarroll 1334obt698apromisingnovelagonisticantibodyforimmunooncologyanditspotentialasacancertherapyforsolidtumors AT arnimabisht 1334obt698apromisingnovelagonisticantibodyforimmunooncologyanditspotentialasacancertherapyforsolidtumors AT chanderpeddaboina 1334obt698apromisingnovelagonisticantibodyforimmunooncologyanditspotentialasacancertherapyforsolidtumors AT haraldhaeske 1334obt698apromisingnovelagonisticantibodyforimmunooncologyanditspotentialasacancertherapyforsolidtumors AT christianrohlff 1334obt698apromisingnovelagonisticantibodyforimmunooncologyanditspotentialasacancertherapyforsolidtumors |